<DOC>
	<DOC>NCT00785954</DOC>
	<brief_summary>The purpose of this study is to determine whether KAI-9803 is safe and effective in reducing infarct size in subjects with ST elevation myocardial infarction (heart attack) undergoing a percutaneous coronary intervention (PCI). A select number of sites will also participate in a substudy where eligible patients will undergo an additional procedure;cardiac magnetic resonance imaging.</brief_summary>
	<brief_title>Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Pathologic Processes</mesh_term>
	<criteria>Acute STEMI and has a planned emergent primary PCI procedure Continuous symptoms of cardiac ischemia and present to the primary PCI facility within 6 hours of symptom onset Persistent systolic blood pressure &lt; 90 mm Hg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Heart Diseases</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Infarction</keyword>
	<keyword>Myocardial Infarction</keyword>
</DOC>